During the past decade, AMITA Health Cancer Institute and Outpatient Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AMITA Health Cancer Institute and Outpatient Center" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AMITA Health Cancer Institute and Outpatient Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator, "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "AMITA Health Cancer Institute and Outpatient Center" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Invasive Breast Carcinoma" (2 trials), "Stage IIA Breast Cancer" (2 trials) and "Stage IIB Breast Cancer" (2 trials). Many other conditions were trialed in "AMITA Health Cancer Institute and Outpatient Center" in a lesser frequency.

Most popular intervention types in "AMITA Health Cancer Institute and Outpatient Center" are "Other" (14 trials), "Drug" (11 trials), "Biological" (7 trials), "Radiation" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (5 trials), "Nivolumab" (4 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "AMITA Health Cancer Institute and Outpatient Center" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "AMITA Health Cancer Institute and Outpatient Center". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in AMITA Health Cancer Institute and Outpatient Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AMITA Health Cancer Institute and Outpatient Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".